Skip to main content
Equibles
CLPT logo

CLPT · ClearPoint Neuro, Inc.

Track CLPT — free

Use CLPT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$14.35 +0.04 (+0.28%)
Russell 2000 member Rebalance outlook locked
Market Cap
$436.52M
Shares
30.50M

CLPT metrics

69 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.31
Market cap
$436.52M

Price action

19 metrics
Price change (1W)
-12.1%
Price change (30D)
-3.1%
Price change (3M)
+20.5%
Price change (6M)
+68.6%
Price change (YTD)
+8.9%
Price change (1Y)
+42.0%
Trailing year
Price change (5Y)
-23.5%
52-week high
$29.60
52-week low
$8.66
Change from 52-week high
-49.7%
Change from 52-week low
+72.1%
Annualized volatility
106.2%
Beta
1.8
RSI (14D)
46.7
Price vs SMA 50
-6.0%
Price vs SMA 200
+10.9%
Avg volume (3M)
725,160
Relative volume
1.1
Average dollar volume
$11.48M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
30.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
10.9×
reciprocal yield 9.2%
P / book
42.7
reciprocal yield 2.3%
FCF yield
-6.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / revenue historical average (5Y)
11.2×
reciprocal yield 8.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
62.6%
Operating margin
-73.4%
Trailing 12 months
Net margin
-81.8%
Gross profit (TTM)
$26.47M
Operating profit (TTM)
−$31.04M
Net income (TTM)
−$34.57M
Trailing 12 months
Diluted EPS (TTM)
$-1.17
FCF margin
-73.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.36

Growth

11 metrics
Revenue growth YoY
+18.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$42.28M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.8%
Year over year · more shares
Revenue CAGR (3Y)
+21.6%
Revenue CAGR (5Y)
+23.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-320.8%
Return on assets
-39.8%
Debt / equity
4.7
Current ratio
4.7
EBITDA (TTM)
−$30.49M
Free cash flow (TTM)
−$31.27M
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$29.36M
Total assets
$86.74M
Total debt
$50.23M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.16M
Capital expenditures (TTM)
$1.11M
R&D (TTM)
$15.84M
SG&A (TTM)
$19.58M
Stock compensation (TTM)
$8.49M
R&D / revenue
37.5%
Stock compensation / revenue
20.1%

Ownership (13F)

3 metrics
13F filers
130
13F filer change QoQ
+8
Institutional ownership
48.4%

Short interest

3 metrics
Short interest
14.7%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.49M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1285550 CUSIP 18507C103 13F (30d) 106 filings 105 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)